Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1047Neoplasms 821Carcinoma, Non-Small-Cell Lung 806Prostatic Neoplasms 628Colorectal Neoplasms 536Lung Neoplasms 489Neoplasm Metastasis 439Multiple Myeloma 399Leukemia, Myeloid, Acute 392Ovarian Neoplasms 336Pancreatic Neoplasms 318Melanoma 300Squamous Cell Carcinoma of Head and Neck 269Recurrence 260Carcinoma, Hepatocellular 251Glioblastoma 241Brain Neoplasms 240Triple Negative Breast Neoplasms 214Head and Neck Neoplasms 211Carcinoma, Renal Cell 211Precursor Cell Lymphoblastic Leukemia-Lymphoma 205Lymphoma 203Stomach Neoplasms 200Endometrial Neoplasms 191Uterine Cervical Neoplasms 185Glioma 184Sarcoma 183Lymphoma, Non-Hodgkin 183Lymphoma, Large B-Cell, Diffuse 168Hematologic Neoplasms 165

Interventions

Sodium Chloride 1Amiodarone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Atrial Fibrillation × 90 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

NCT07518446 2026-04-08

SomaScreen

Amager Hospital

Phase NA Recruiting
2,800 enrolled

Asthma, Atrial Fibrillation, Mental Disorders, Diabetes Mellitus, Disease, Heart Failure, Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡